GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q1 2017. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $247,000 | -31.2% | 6,528 | -14.6% | 0.20% | -14.5% |
Q4 2019 | $359,000 | +303.4% | 7,646 | +266.0% | 0.23% | +260.0% |
Q3 2019 | $89,000 | +6.0% | 2,089 | +0.1% | 0.06% | +1.6% |
Q2 2019 | $84,000 | -3.4% | 2,086 | +0.1% | 0.06% | -5.9% |
Q1 2019 | $87,000 | +10.1% | 2,083 | +0.1% | 0.07% | -5.6% |
Q4 2018 | $79,000 | -4.8% | 2,081 | +0.1% | 0.07% | +26.3% |
Q3 2018 | $83,000 | -1.2% | 2,078 | -0.4% | 0.06% | -8.1% |
Q2 2018 | $84,000 | +3.7% | 2,087 | +0.1% | 0.06% | +1.6% |
Q1 2018 | $81,000 | +11.0% | 2,084 | +0.1% | 0.06% | +13.0% |
Q4 2017 | $73,000 | -13.1% | 2,081 | +0.1% | 0.05% | -14.3% |
Q3 2017 | $84,000 | -5.6% | 2,079 | +0.7% | 0.06% | -13.7% |
Q2 2017 | $89,000 | +2.3% | 2,064 | +0.1% | 0.07% | +4.3% |
Q1 2017 | $87,000 | +14.5% | 2,062 | +5.1% | 0.07% | +2.9% |
Q4 2016 | $76,000 | -5.0% | 1,962 | +5.4% | 0.07% | -6.8% |
Q3 2016 | $80,000 | -1.2% | 1,862 | 0.0% | 0.07% | -16.1% |
Q2 2016 | $81,000 | -59.3% | 1,862 | -62.1% | 0.09% | -54.2% |
Q1 2016 | $199,000 | +155.1% | 4,918 | +153.2% | 0.19% | +167.6% |
Q4 2015 | $78,000 | – | 1,942 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |